Imunon
IMNN
21 hedge funds and large institutions have $818K invested in Imunon in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0.47% less ownership
Funds ownership: 0.99% → 0.53% (-0.47%)
13% less funds holding
Funds holding: 24 → 21 (-3)
51% less capital invested
Capital invested by funds: $1.69M → $818K (-$868K)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$69K |
| 2 |
VF
Virtu Financial
New York
|
+$23.5K |
| 3 |
Renaissance Technologies
New York
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$509K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$178K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$95K |
| 4 |
Two Sigma Advisers
New York
|
-$48K |
| 5 |
Two Sigma Investments
New York
|
-$37K |
IMNN Hedge Fund Activity: Q3 2022 in Review
21 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2022, worth a combined $818K — down 51% from $1.69M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IMNN and 2 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $69K. The largest seller was Murchinson, exiting entirely with an estimated $509K sold.
- 21 institutional investors held Imunon (IMNN) as of Q3 2022, down from 24 in Q2 2022.
- Funds reported $818K of Imunon stock for Q3 2022, down 51% quarter-over-quarter.
- 2 funds opened new Imunon positions in Q3 2022 and 5 closed out, a net change of -3 holders.
- The largest Imunon buyer in Q3 2022 was Citadel Advisors, an estimated $69K added.
- The largest Imunon seller in Q3 2022 was Murchinson, an estimated $509K sold.
Based on aggregated 13F filings for Q3 2022.